succinic acid has been researched along with Encephalomyelitis, Subacute Necrotizing in 2 studies
Succinic Acid: A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)
succinic acid : An alpha,omega-dicarboxylic acid resulting from the formal oxidation of each of the terminal methyl groups of butane to the corresponding carboxy group. It is an intermediate metabolite in the citric acid cycle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakare, AB | 1 |
| Rao, RR | 1 |
| Iyer, S | 1 |
| Ehinger, JK | 1 |
| Piel, S | 1 |
| Ford, R | 1 |
| Karlsson, M | 1 |
| Sjövall, F | 1 |
| Frostner, EÅ | 1 |
| Morota, S | 1 |
| Taylor, RW | 1 |
| Turnbull, DM | 1 |
| Cornell, C | 1 |
| Moss, SJ | 1 |
| Metzsch, C | 1 |
| Hansson, MJ | 1 |
| Fliri, H | 1 |
| Elmér, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mitochondrial Targeted Biofuels as Countermeasures Against Chemical Threats[NCT03597438] | 700 participants (Anticipated) | Observational | 2018-05-07 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for succinic acid and Encephalomyelitis, Subacute Necrotizing
| Article | Year |
|---|---|
Cell-Permeable Succinate Increases Mitochondrial Membrane Potential and Glycolysis in Leigh Syndrome Patient Fibroblasts.
Topics: Case-Control Studies; Citric Acid Cycle; DNA, Mitochondrial; Electron Transport Complex I; Energy Me | 2021 |
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency.
Topics: Cell Membrane Permeability; Cell Respiration; Drug Discovery; Drug Evaluation, Preclinical; Electron | 2016 |